Amgen Full Year 2025 Financial ReportAmgenAmgen's 2025 revenue rose 10%, reaching $36.75B, driven by strong product sales and innovation. The company projects continued growth in 2026, with a focus on R&D, cost control, and shareholder returns.
ASCO 2025: Opening a New Era of "Cancer Eradication"ASCODiscover the latest breakthroughs from ASCO 2025, including innovative cancer treatments, immunotherapy advances, bispecific antibodies, and promising breast cancer therapies shaping the future of oncology.
Top 16 Best-Selling New Drugs Worldwide in 2024Market TrendDiscover the top 16 best-selling new drugs of 2024, featuring innovative FIC and BIC molecules, breakthrough therapies across various fields, and products that stood out due to unique development strategies.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024AutoimmuneThe autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Biotech Giants Performance Comparison 2024Market TrendCompare the 2024 financial performance of top biotech giants, including Vertex, Amgen, Gilead, Regeneron, and Biogen. Explore revenue, net profit, R&D investment, and market trends shaping the biotech industry.
Amgen 2024 Q4 Financial ReportFinancial statementsAmgen reports strong 2024 earnings but faces a setback as the FDA halts its obesity drug AMG 513. Despite this, progress continues with other promising weight loss candidates like MariTide.
Top 10 Immunology Drugs to Watch in 2024AbbVieExplore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
